| Pharmacotherapy for the treatment of overweight and obesity in children, adolescents, and young adults in a large health system in the US KS Czepiel, NP Perez, KJ Campoverde Reyes, S Sabharwal, FC Stanford Frontiers in Endocrinology 11, 525609, 2020 | 47 | 2020 |
| Treatment of obesity: pharmacotherapy trends of office-based visits in the United States from 2011 to 2016 MD Claridy, KS Czepiel, SS Bajaj, FC Stanford Mayo Clinic Proceedings 96 (12), 2991-3000, 2021 | 21 | 2021 |
| Exploring pediatric obesity training, perspectives, and management patterns among pediatric primary care physicians KJ Campoverde Reyes, NP Perez, KS Czepiel, AY Shaw, FC Stanford Obesity 29 (1), 159-170, 2021 | 16 | 2021 |
| Dexmedetomidine-associated hyperpyrexia in three critically ill patients with coronavirus disease 2019 KS Czepiel, AT Lucas, MJ Whalen, JE Mojica Critical care explorations 2 (9), e0213, 2020 | 16 | 2020 |
| Food as medicine for obesity treatment and management VR Johnson, TB Washington, S Chhabria, EHC Wang, K Czepiel, ... Clinical therapeutics 44 (5), 671-681, 2022 | 14 | 2022 |
| Preoperative considerations for the pediatric patient undergoing metabolic and bariatric surgery JSA Pratt, SS Roque, R Valera, KS Czepiel, DD Tsao, FC Stanford Seminars in pediatric surgery 29 (1), 150890, 2020 | 13 | 2020 |
| Bariatric surgery in the treatment of adolescent obesity: current perspectives in the United States S Malhotra, KS Czepiel, EY Akam, AY Shaw, R Sivasubramanian, ... Expert review of endocrinology & metabolism 16 (3), 123-134, 2021 | 11 | 2021 |
| Strategies in the management of adolescent obesity VR Johnson, M Cao, KS Czepiel, T Mushannen, LS Nolen, FC Stanford Current pediatrics reports 8, 56-65, 2020 | 8 | 2020 |
| Pharmacotherapy for weight loss in children, adolescents, and young adults: an evaluation of current on-and off-label usage KS Czepiel, NP Perez, KJ Campoverde Reyes, S Sabharwal, FC Stanford Pediatrics 147 (3_MeetingAbstract), 180-181, 2021 | 2 | 2021 |
| They didn’t cover this in lecture: the formation and dissolution of the patient-provider relationship KS Czepiel Perspectives on Medical Education 7, 16-17, 2018 | 1 | 2018 |
| The Many Names of Fatty Liver Disease: Strengths and Limitations of Metabolic (Dysfunction)-Associated Fatty Liver Disease KS Czepiel, FC Stanford Childhood Obesity 19 (1), 1-2, 2023 | | 2023 |
| Association Between Weight Promoting Medication Use and Weight Status Among Children and Adolescents in the United States MD Claridy, NP Perez, KS Czepiel, NO Acholonu, FC Stanford Academic pediatrics 23 (1), 102-108, 2023 | | 2023 |
| Haploinsufficiency of NPM1 in AML Derived NPM1 Mutant (NPMc+) Expressing Cells Contributes to Aberrant C/EBPα Activity K Czepiel, K Nichol, M Tippy, N Abayasekara, J Lee, E Wajswol, ... Blood 124 (21), 2188, 2014 | | 2014 |
